Study finds that lower dose of cannabidiol is as effective as higher dose in Dravet Syndrome.

A Phase 3 study presented at the American Academy of Neurology's Annual Meeting in Philadelphia has provided new evidence of the benefits of pharmaceutical-grade cannabidiol (Epidiolex) in treating Dravet Syndrome. Dravet Syndrome is an infantile onset developmental and epileptic encephalopathy associated with drug-resistant seizures. 

Update on Frisium Supply

Epilepsy Ireland has been made aware of reports of difficulties with the supply of Frisium (Clobazam) 10 mg tablets recently.  We have contacted the Irish Pharmaceutical Union and also the Health Products Regulation Authority to clarify what the position is currently.

There had been a delay with production of Frisium which led to stock being made available on a case by case basis in Ireland by the manufacturers Sanofi.